ETFis Series Trust I. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| DREYFUS GOVERNMENT CASH MANAGECash or money market | 3.48% | $1.61M | 1,612,819 |
| FIRST TRACKS BIOTHERAPEUTICS INCTRAX | 1.67% | $775.98K | 17,620 |
| MBX BIOSCIENCES INCMBX | 1.24% | $577.15K | 8,754 |
| ATAIBECKLEY INC | 1.23% | $569.30K | 79,289 |
| MONOPAR THERAPEUTICS INCMNPR | 1.21% | $563.42K | 5,200 |
| DEFINIUM THERAPEUTICS INCDFTX | 1.18% | $546.52K | 12,558 |
| XENCOR INCXNCR | 1.10% | $509.45K | 25,208 |
| ZENAS BIOPHARMA INCZBIO | 1.06% | $493.51K | 15,697 |
| UNIQURE NV | 1.06% | $491.84K | 11,273 |
| APOGEE THERAPEUTICS INC | 1.02% | $471.86K | 3,519 |
| VOR BIOPHARMA INCVOR | 0.99% | $457.77K | 21,644 |
| REGENXBIO INCRGNX | 0.97% | $452.23K | 46,670 |
| LB PHARMACEUTICALS INCLBRX | 0.94% | $438.31K | 10,936 |
| DAMORA THERAPEUTICS INC | 0.93% | $433.60K | 14,957 |
| AMYLYX PHARMACEUTICALS INCAMLX | 0.93% | $432.66K | 21,303 |
| DYNE THERAPEUTICS INCDYN | 0.93% | $430.25K | 17,087 |
| ORUKA THERAPEUTICS INCORKA | 0.93% | $429.18K | 4,447 |
| NURIX THERAPEUTICS INCNRIX | 0.92% | $425.60K | 18,337 |
| ORIC PHARMACEUTICALS INCORIC | 0.90% | $416.07K | 37,585 |
| GH RESEARCH PLC | 0.89% | $413.08K | 14,716 |
| SIONNA THERAPEUTICS INCSION | 0.88% | $407.82K | 8,653 |
| DIANTHUS THERAPEUTICS INCDNTH | 0.87% | $404.91K | 3,787 |
| ERASCA INCERAS | 0.87% | $401.51K | 22,122 |
| JADE BIOSCIENCES INCJBIO | 0.86% | $400.15K | 20,261 |
| SELLAS LIFE SCIENCES GROUP INCSLS | 0.86% | $397.35K | 39,695 |
| PALVELLA THERAPEUTICS INCPVLA | 0.86% | $397.10K | 2,856 |
| RELAY THERAPEUTICS INCRLAY | 0.85% | $395.22K | 20,989 |
| REPLIMUNE GROUP INCREPL | 0.84% | $392.01K | 35,001 |
| ALTO NEUROSCIENCE INCANRO | 0.84% | $391.87K | 14,476 |
| ADLAI NORTYE LTDANL | 0.84% | $391.52K | 30,117 |
| BICARA THERAPEUTICS INCBCAX | 0.84% | $388.37K | 14,331 |
| IMMUNOME INCIMNM | 0.83% | $384.89K | 16,911 |
| AVALO THERAPEUTICS INCAVTX | 0.83% | $384.31K | 21,058 |
| MEIRAGTX HOLDINGS PLC | 0.82% | $382.11K | 32,410 |
| IDEAYA BIOSCIENCES INCIDYA | 0.82% | $380.74K | 10,725 |
| SPYGLASS PHARMA INCSGP | 0.82% | $379.74K | 16,855 |
| KODIAK SCIENCES INCKOD | 0.82% | $379.42K | 9,125 |
| REVOLUTION MEDICINES INCRVMD | 0.82% | $378.81K | 2,020 |
| CELLDEX THERAPEUTICS INCCLDX | 0.82% | $378.32K | 9,940 |
| SPYRE THERAPEUTICS INCSYRE | 0.82% | $378.28K | 3,847 |
| CULLINAN THERAPEUTICS INCCGEM | 0.81% | $374.34K | 22,687 |
| LEXICON PHARMACEUTICALS INCLXRX | 0.81% | $373.95K | 161,882 |
| XENON PHARMACEUTICALS INCXENE | 0.81% | $373.89K | 5,966 |
| KYMERA THERAPEUTICS INCKYMR | 0.80% | $372.76K | 3,605 |
| BIOHAVEN LTD | 0.80% | $371.98K | 27,554 |
| CG ONCOLOGY INCCGON | 0.80% | $371.47K | 5,218 |
| NEKTAR THERAPEUTICSNKTR | 0.80% | $369.89K | 5,234 |
| ENLIVEN THERAPEUTICS INCELVN | 0.80% | $369.31K | 6,738 |
| ARCUS BIOSCIENCES INCRCUS | 0.79% | $368.16K | 13,060 |
| TYRA BIOSCIENCES INCTYRA | 0.79% | $367.13K | 11,516 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.